ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BNTX BioNTech SE

92.25
-0.72 (-0.77%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 433,117
Bid Price 91.65
Ask Price 93.50
News -
Company Name Stock Ticker Symbol Market Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.72 -0.77% 92.25 20:00:00
Open Price Low Price High Price Close Price Prev Close
92.90 92.20 93.8425 92.25 92.97
Trades Volume VWAP Dollar Volume Avg Volume
8,131 433,117  92.91  40,241,849 -
Last Trade Time Type Quantity Stock Price Currency
19:35:10 1  92.30 USD

BioNTech (BNTX) Options Flow Summary

Overall Flow

Bullish

Net Premium

31k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

BioNTech SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 17.31B 9.43B - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News BioNTech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BNTX Message Board. Create One! See More Posts on BNTX Message Board See More Message Board Posts

BNTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.

Your Recent History

Delayed Upgrade Clock